COMPARATIVE RESULTS OF RECOMBINANT NON-IMMUNOGENIC STAPHYLOKINASE AND TENECTEPLASE USE IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IN REAL CLINICAL PRACTICE

COMPARATIVE RESULTS OF RECOMBINANT NON-IMMUNOGENIC STAPHYLOKINASE AND TENECTEPLASE USE IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IN REAL CLINICAL PRACTICE

Aim. To compare the efficacy and safety of thrombolytic therapy with recombinant non-immunogenic staphylokinase and tenecteplase in ST elevation myocardial infarction (STEMI) in real clinical practice.Material and methods. 84 patients with onset of STEMI symptoms up to 12 hours ago were included int...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. S. Mazur, R. M. Rabinovich, V. V. Mazur, N. S. Kuznetsova, E. A. Kudryashova, S. V. Veselov, V. V. Bobkov, D. Yu. Platonov
Format:	Article
Language:	English
Published:	Столичная издательская компания 2017-09-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	st elevation myocardial infarction fibrinolysis coronary blood flow recombinant non-immunogenic staphylokinase tenecteplase
Online Access:	https://www.rpcardio.online/jour/article/view/1505
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

RESULTS OF HOSPITAL USE OF RECOMBINANT NON-IMMUNOGENIC STAPHYLOKINASE IN PATIENTS WITH ST-ELEVATED MYOCARDIAL INFARCTION
by: V. B. Kostogryz
Published: (2017-03-01)

Assessment of the allergenic and immunotoxic properties of the recombinant non-immunogenic staphylokinase in preclinical and clinical trials
by: S. S. Markin, et al.
Published: (2025-07-01)

Clinical case of the non-immunogenic recombinant staphylokinase usage in the treatment of massive pulmonary embolism in patient with genetically determined thrombophilia
by: G. D. Azizova, et al.
Published: (2025-04-01)

THE RESULTS OF USE OF NEW NATIVE THROMBOLYTIC IN CLINICAL PRACTICE
by: E. S. Mazur, et al.
Published: (2016-05-01)

Non-immunogenic staphylokinase — a thrombolytic agent in the treatment of massive pulmonary embolism: results of the FORPE clinical trial
by: A. I. Kirienko, et al.
Published: (2024-12-01)

Some Aspects of Prehospital Thrombolytic Therapy in the Perm Region
by: S. A. Naumov, et al.
Published: (2018-09-01)

Non-immunogenic staphylokinase in the treatment of high-risk massive pulmonary embolism in the early postoperative period due to femoral fragment wound
by: S. L. Konstantinov, et al.
Published: (2023-11-01)

COST-EFFECTIVENESS EVALUATION OF PREHOSPITAL THROMBOLYSIS WITH TENECTEPLASE
by: V. V. Omel'yanovskiy, et al.
Published: (2016-01-01)

The Safety of Non‐immunogenic Recombinant Staphylokinase in Elderly Patients With Massive Pulmonary Embolism: A Randomized Clinical Trial FORPE
by: Stanislav G. Leontyev, et al.
Published: (2025-05-01)

CLINICAL RESULTS OF THROMBOLYTIC THERAPY WITH ALTEPLASE AND TENECTEPLASE IN PATIENTS WITH MYOCARDIAL INFARCTION
by: L. A. Bondarenko, et al.
Published: (2015-12-01)

Non-immunogenic staphylokinase in patients with massive intermediate-high risk pulmonary embolism: protocol of the FORPE-2 multicenter, double-blind, randomized, placebo-controlled trial
by: S. N. Tereshchenko, et al.
Published: (2025-03-01)

Non-immunogenic staphylokinase in the high-risk pulmonary embolism treatment with subdural hematoma
by: S. L. Konstantinov, et al.
Published: (2025-08-01)

Prolonged Successful Cardiopulmonary Resuscitation with Thrombolysis in a Patient with Acute Coronary Syndrome
by: G. V. Klein, et al.
Published: (2019-01-01)

THE RELEVANCE OF THROMBOLYTIC THERAPY IN ST ELEVATION MYOCARDIAL INFARCTION
by: N. V. Teplova, et al.
Published: (2014-05-01)

Plasminogen activators in acute management of thrombosis
by: E. O. Taratukhin
Published: (2013-06-01)

APPROACHES TO INCREASE THE AVAILABILITY AND EFFECTIVENESS OF PRE-HOSPITAL THROMBOLYSIS IN REAL CLINICAL PRACTICE
by: L. A. Ostroumova, et al.
Published: (2015-12-01)

THROMBOLYSIS OR PRIMARY PCI FOR MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION? THE STREAM TRIAL (STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION)
by: V. A. Sulimov
Published: (2015-09-01)

Primary angioplasty and pharmaco-invasive strategies in the treatment of ST-elevated myocardial infarction
by: M. G. Glezer, et al.
Published: (2019-04-01)

Tenecteplase in acute ischemic stroke: a new era in thrombolysis
by: Gisele Sampaio Silva, et al.
Published: (2025-05-01)

Detection of Sak Gene and Expression of Staphylokinase in Different Clinical Isolates of Staphyloccocus spp.
by: Suha Maher Abed, et al.
Published: (2018-04-01)

Successful use of intra venous tenecteplase for acute ischemic stroke in pregnancy
by: Balamurugan Namasivayam, et al.
Published: (2024-09-01)

Tenecteplase for Minor Stroke: Does Sex Matter?
by: Beom Joon Kim
Published: (2025-05-01)

Tenecteplase compared to alteplase in real-world outcome: A Swedish Stroke Register study
by: Mikael Skärlund, et al.
Published: (2024-10-01)

Alteplase vs. Tenecteplase: An In-depth Analysis of Their Relative Effectiveness in Treating Acute Ischemic Stroke
by: Muhammad Junaid Azhar, et al.
Published: (2024-10-01)

Tenecteplase is here: navigating the shift of a stroke thrombolytic in the United States prior to FDA approval: a mini-review on rationale, barriers, and pathways
by: Julian M. Burwell, et al.
Published: (2025-04-01)

Tenecteplase versus alteplase in patients with acute ischemic stroke: an updated systematic review and meta-analysis
by: Abdelmonam M. Hagag, et al.
Published: (2025-08-01)

Effect of Time Delay on Reperfusion After Tenecteplase in an Extended Time Window: Analysis From the CHABLIS‐T Trials
by: Lan Hong, et al.
Published: (2025-06-01)

Randomised immunogenicity trial comparing 2019-2020 recombinant and egg-based influenza vaccines among frequently vaccinated healthcare personnel in Israel
by: Ashley L. Fowlkes, et al.
Published: (2024-12-01)

RISKS AND BENEFITS OF REPERFUSION STRATEGIES IN ACUTE MYOCARDIAL INFARCTION WITH ST SEGMENT ELEVATION
by: T. M. Poponina, et al.
Published: (2010-10-01)

Tenecteplase Versus Alteplase in Acute Ischemic Stroke in Chinese Patients: Protocol for the ORIGINAL Study
by: Xia Meng, et al.
Published: (2024-07-01)

EFFECTS OF DIFFERENT ADJUVANTS UPON IMMUNOGENICITY OF ANTI-GROUP B STREPTOCOCCAL VACCINE COMPONENTS
by: A. N. Suvorov, et al.
Published: (2014-07-01)

Tenecteplase vs alteplase as bridging thrombectomy in ischemic stroke patients: a systematic review and meta analysis
by: Salim Harris, et al.
Published: (2025-08-01)

Tenecteplase Beyond 4.5 Hours in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
by: Mohammad Aladawi, et al.
Published: (2025-05-01)

CLINICAL CASE OF RUSSIAN THROMBOLYTIC AGENT FORTELYZIN® USE IN PATIENTS WITH ACUTE CORONARY ARTERY DISEASE
by: K. A. Kireev, et al.
Published: (2015-09-01)

Switch to tenecteplase for intravenous thrombolysis in stroke patients: experience from a German high-volume stroke center
by: Alexander Sekita, et al.
Published: (2025-05-01)

Efficacy and Safety of Intravenous Tenecteplase Before Endovascular Thrombectomy for Acute Ischemic Stroke: The Multicenter, Randomized, BRIDGE‐TNK Trial Protocol
by: Zhongming Qiu, et al.
Published: (2024-11-01)

CORONARY REPERFUSION IN ST ELEVATION MYOCARDIAL INFARCTION: PROBLEMS AND SOLUTIONS
by: V. A. Markov, et al.
Published: (2015-01-01)

COMPARISON OF COLORIMETRIC AND CHEMILUMINESCENT ELISA TESTS FOR DETECTION OF IgG ANTIBODIES TO HUMAN EPO IN THE SERA OF EXPERIMENTAL ANIMALS
by: A. M. Kudryashova, et al.
Published: (2018-12-01)

Immunogenicity of various variants of Ebola and Marburg virus glycoprotein genes in recombinant adenoviral vectors
by: T. A. Ozharovskaia, et al.
Published: (2024-10-01)

Immunogenicity and safety of concomitant administration of recombinant COVID-19 vaccine and quadrivalent inactivated influenza vaccine in Chinese adults: An open-label, randomized, controlled trial
by: Tao Huang, et al.
Published: (2024-12-01)